Project description
The concept of “Developmental Origins of Health and Disease (DOHD)”, popularized by the WHO under the name “the first 1000 days of life”, from the conception to the child's two years of age, is an integral part of current public health issues. This period is punctuated by extensive growth and constitutes a unique and critical window for the development of major physiological systems, determining future health status.
Numerous epidemiological and experimental observations have demonstrated that exposure of this critical window to chemical, nutritional, social or psychosocial disturbances such as chronic stress during pregnancy, results in a predisposition to the development of metabolic, neuropsychic, inflammatory or non-inflammatory pathologies such as irritable bowel syndrome (IBS). IBS is the most common gastrointestinal disorder with a global prevalence of 5% and affects twice women than men.
The notion of “functional disorder” results from the absence of quantifiable criteria in favor of an organic disorder. IBS, which is characterized by chronic visceral pain associated with transit disorders is define as an alteration of the microbiota-gut-brain axis. Recently, we demonstrated that prenatal stress induced visceral hypersensivity in mice. This hypersensitivity was correlated with taxonomic and functional dysbiosis of the microbiota.
Among the three stages, which are crucial for the establishment of the intestinal microbiota: primary colonization by the maternal vaginal microbiota, lactation and weaning, we highlighted the importance of lactation in PS-induced visceral sensitivity phenotype.
International grant's winning projects
Bifidobacterium-derived peptides to fortify the intestinal mucosa in early life
Linking the early life resistome and microbiome maturation
Randomized controlled trial evaluating the effect of transplantation of fecal microbiota in children with autism spectrum disorders and gastrointestinal symptoms
Clostridium difficile-induced post-infectious Irritable Bowel Syndrome: Study of the mechanisms and treatments
Targeting gut microbial drug metabolism to enhance the treatment of Parkinson’s disease
A precision medicine approach to treat alcoholic hepatitis